随着更多相关变异得到识别，研究人员也就能够清楚精神分裂症的原因，而不会钉死在一个或几种基因，或一种生理途径上。
As more related variants are identified, it has become clear to researchers that the cause of schizophrenia will never be pinned on one or several genes or one physiological pathway.
在大规模基因猎获中，三组国际精神分裂症研究人员已将目光锁定在几种藏有精神分裂症之谜的变异上。
In a massive gene hunt, three groups of international schizophrenia researchers have zeroed in on several mutations that harbor some of the secrets of schizophrenia.
这一研究的结果可能会对我们理解在像如精神分裂症一类的神精精神病里才会发现的显著脑部异常的重要功能。
The results could have implications for understanding the functional significance of a prominent brain abnormality observed in neuropsychiatric diseases such as schizophrenia.
他们的这组研究包括了69个具有精神分裂症或情感分裂性精神障碍的实验对象，年龄在18到60岁之间，都在服用抗精神病药物，且病情稳定。
The cohort of their study included 69 subjects with schizophrenia or schizoaffective disorder, aged 18 to 60, and all on antipsychotic medications and stable.
MGS研究也发现精神分裂症与1号染色体(1 p 22 . 1)遗传变异间的联系，这种联系在多发性硬化中已经有过。
The MGS study also found an association between schizophrenia and a genetic variation on chromosome 1 (1p22.1), which has been implicated in multiple sclerosis.
研究人员声称，涉及到大量普通基因变异表明精神分裂症在不同的人身上可以最终追踪到不同(distinct ？)的疾病过程。
This involvement of many common gene variants suggests that schizophrenia in different people might ultimately be traceable to distinct disease processes, say the researchers.
研究报告发表在1月9日出版的《美国人类学遗传》杂志上，研究小组描述了neuregulin3基因的变异影响着和精神分裂症及相关的妄想症。
Reporting in the Jan. 9 issue of the American Journal of Human Genetics, the team describes how a variation in the neuregulin 3 gene influences delusions associated with schizophrenia.
这种方法在以前曾用于研究和治疗不管是精神分裂症还是极度消沉引起的神经混乱，也被证明在棍棒击打后的治疗恢复上有限制功效。
It has been used in the past to study and treat mental disorders from schizophrenia to depression, and has also proven an effective therapy for rehabilitating stroke victims.
目的：探讨短期系统家庭治疗联合药物治疗与单纯药物治疗在改善精神分裂症患者精神症状及家庭功能的疗效对照研究。
Objective: to evaluate the Psychiatric symptoms and the family functions between the short-term Systemic family Therapy (SFT) associated with drugs and the drugs alone for schizophrenics.
研究二：精神疾病病耻感量表中文版的信度和效标关联效度均较理想，结构效度在分析调整后也较理想，符合心理测量学要求，可用于国内精神分裂症患者病耻感研究。
In study two, the SSMI-C has good psychometrics properties, with adequate reliability and validity, and can be applicable to assess the stigma of Chinese patients with schizophrenia.
研究二：精神疾病病耻感量表中文版的信度和效标关联效度均较理想，结构效度在分析调整后也较理想，符合心理测量学要求，可用于国内精神分裂症患者病耻感研究。
In study two, the SSMI-C has good psychometrics properties, with adequate reliability and validity, and can be applicable to assess the stigma of Chinese patients with schizophrenia.
应用推荐